Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP439441.RAg-IEFn7J39dl8sCLHBuOck7aAVQW0iAl3nvoc-6Hv_c130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439441.RAg-IEFn7J39dl8sCLHBuOck7aAVQW0iAl3nvoc-6Hv_c130_provenance.
• NP674563.RAaM84B2c_akpoa-Pre9Hlx_5p0ck4jr4wYdLitkaM9vw130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674563.RAaM84B2c_akpoa-Pre9Hlx_5p0ck4jr4wYdLitkaM9vw130_provenance.
• NP577576.RASmd3349_ycJqV6rs0h0rnpbotiQNSmQf4cypkGiRatw130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577576.RASmd3349_ycJqV6rs0h0rnpbotiQNSmQf4cypkGiRatw130_provenance.
• assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951269.RASjqTo7IU0MzRwq68tBl1LrPhHcnUrCrO8NO_age5qfs130_provenance.
• NP795773.RAB6N3aTD-jA0C9FsHO3q6JwU2rKFUEJuD3kHvUPhCTm4130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795773.RAB6N3aTD-jA0C9FsHO3q6JwU2rKFUEJuD3kHvUPhCTm4130_provenance.
• NP577727.RAnDSYsx9857qoQRTC7vhAxuFfg2cTm1fsQhRBwqK44dI130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577727.RAnDSYsx9857qoQRTC7vhAxuFfg2cTm1fsQhRBwqK44dI130_provenance.
• NP67739.RA5Cn2qj21kPqGmG0ZWX2ghf_lNU1q42EB7TY3xn8YcLM130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67739.RA5Cn2qj21kPqGmG0ZWX2ghf_lNU1q42EB7TY3xn8YcLM130_provenance.
• NP795768.RAoi1nkmf70hbJ0D5jbFbw1v0JrMi2N9nngLdWTRCkMGM130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795768.RAoi1nkmf70hbJ0D5jbFbw1v0JrMi2N9nngLdWTRCkMGM130_provenance.
• NP795774.RAqy38G7rL4FVE0qQW0lRvarPApVucPgTbh7ItrZgRaGE130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795774.RAqy38G7rL4FVE0qQW0lRvarPApVucPgTbh7ItrZgRaGE130_provenance.
• NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_provenance.
• NP165285.RAJEv4f8962DHjFMPAOomVXvKuACfyKnVasupdf9WG_V4130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165285.RAJEv4f8962DHjFMPAOomVXvKuACfyKnVasupdf9WG_V4130_provenance.
• NP951052.RA4aNaZZ7Oj8w5ymIbqxmBERATlhp7uBGLF76dPHnDdZw130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951052.RA4aNaZZ7Oj8w5ymIbqxmBERATlhp7uBGLF76dPHnDdZw130_provenance.
• NP165280.RAxPVZKp740P-TdvgYwcivzODRWbjBNS-knEdTYSuKc-4130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165280.RAxPVZKp740P-TdvgYwcivzODRWbjBNS-knEdTYSuKc-4130_provenance.
• NP795771.RA6SYK7vfEwC0DS7n4YIuecV8vUXpUarG6bQgqqs1yckw130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795771.RA6SYK7vfEwC0DS7n4YIuecV8vUXpUarG6bQgqqs1yckw130_provenance.